Eliem Therapeutics Inc. (ELYM)
NASDAQ: ELYM
· Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM
Eliem Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -20.78M | -13.67M | -8.89M | -54.89M | -1.7M | -3.64M | -3.97M | -5.22M | -22.29M | -7.76M | -9.68M | -14.6M | -13.2M | -10.54M | -9.62M | -8.72M | -18.6M |
Depreciation & Amortization | -669K | -1.19M | -169K | n/a | -63K | 491K | n/a | n/a | -491K | -293K | n/a | 293K | 193K | 370K | n/a | n/a | n/a |
Stock-Based Compensation | 2.02M | 3.38M | 2.92M | 512K | 465K | 1.2M | 656K | 777K | 10.17M | 1.9M | 1.78M | 1.77M | 1.54M | 1.15M | 1.24M | 1.05M | 297K |
Other Working Capital | n/a | -3.43M | -1.09M | 1.98M | -640K | 2.09M | 7.62M | -2.69M | -114K | 260K | 2.28M | -2.55M | 892K | 2.39M | -5.12M | -598K | -993K |
Other Non-Cash Items | n/a | 2.11M | -73K | 52.24M | 518K | 71K | -671K | -850K | -109K | -415K | 112K | 967K | 478K | 1.76M | 4K | -85K | 11.64M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.39M | n/a | n/a | -193K | -1.84M | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.76M | -1.31M | 1.98M | -640K | 1.42M | 7.47M | -2.67M | -2.46M | -484K | 2.69M | -2.4M | 406K | 1.22M | -4.59M | -727K | -73K |
Operating Cash Flow | -15.43M | -12.13M | -7.55M | -667K | -1.82M | -947K | 3.49M | -7.96M | -15.18M | -8.45M | -4.17M | -13.97M | -10.78M | -7.88M | -12.97M | -8.48M | -6.74M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | -4.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -58.75M | -132.2M | -71.79M | n/a | n/a | -1K | -2.46M | -38.53M | -17.45M | -6.71M | -46.74M | -8.93M | -25.58M | -8.05M | -106.92M | n/a | n/a |
Sales Maturities Of Investments | 16M | -29.75M | n/a | n/a | 13.75M | 36.75M | 30.5M | 36.93M | 23.25M | 20.99M | 55.25M | 24.61M | 21.55M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -5M | 13.75M | 36.75K | 28.04K | -1.6K | 5.8K | 14.28K | 8.51M | 15.69K | -4.04M | -8.05M | -106.92M | n/a | n/a |
Investing Cash Flow | -42.75M | -161.95M | -71.79M | -9.64M | 13.75M | 36.75M | 28.04M | -1.6M | 5.8M | 14.28M | 8.51M | 15.69M | -4.04M | -8.05M | -106.92M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.14M | n/a | -4.55M | n/a | -2.14M | n/a |
Other Financial Acitivies | n/a | 10.98M | 2.27M | 128.4M | 15K | 288K | 528K | 24K | 1K | n/a | n/a | 2.14M | n/a | 38K | 83.14M | 2.15M | 105K |
Financial Cash Flow | n/a | 2.02M | 2.27M | 128.4M | 15K | 288K | 528K | 24K | 1K | n/a | n/a | -2.14M | n/a | 38K | 83.14M | 59.97M | 34.08M |
Net Cash Flow | -58.21M | -135.91M | -76.97M | 118.11M | 11.92M | 35.76M | 32.06M | -9.14M | -9.15M | 7.64M | 3.34M | 671K | -14.99M | -15.9M | -36.66M | 51.57M | 27.42M |
Free Cash Flow | -15.43M | -12.13M | -7.55M | -667K | -1.82M | -947K | 3.49M | -7.96M | -15.18M | -8.45M | -4.17M | -13.97M | -10.78M | -7.88M | -12.97M | -8.48M | -6.74M |